Champions Oncology (CSBR) Operating Expenses (2010 - 2026)

Champions Oncology's Operating Expenses history runs 17 years deep, the most recent figure standing at $16.8 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 34.25% year-over-year to $16.8 million; the TTM figure through Jan 2026 stood at $60.6 million (up 15.81% YoY), while the FY2025 annual figure was $52.4 million, down 8.9% from the prior year.
• Operating Expenses was $16.8 million for Q1 2026 at Champions Oncology, up from $14.8 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $16.8 million in Q1 2026 to a low of $12.4 million in Q1 2022.
• Historically, Operating Expenses has averaged $14.2 million across 5 years, with a median of $14.3 million in 2022.
• The sharpest annual moves came in 2024 and 2026: Operating Expenses slipped 15.75% in 2024, then jumped 34.25% in 2026.
• A 5-year view of Operating Expenses shows it stood at $14.3 million in 2022, then dropped by 5.23% to $13.5 million in 2023, then decreased by 5.7% to $12.8 million in 2024, then rose by 16.41% to $14.8 million in 2025, then gained by 13.37% to $16.8 million in 2026.
• The last three Operating Expenses figures came in at $16.8 million (Q1 2026), $14.8 million (Q4 2025), and $14.5 million (Q3 2025), per Business Quant data.